Implementation and Testing of Enzyme Linked Immunosorbent Assay for the Detection of SARS-CoV-2 Receptor Binding Domain Antibodies

Authors

Emilly G. Sanchez, The University of Texas MD Anderson Cancer CenterFollow
Claudia Paindelli, The University of Texas MD Anderson Cancer Center
Eleonora Dondossola, The University of Texas MD Anderson Cancer Center
Sarah B. Johnson, The University of Texas MD Anderson Cancer Center
Pranoti V. Sahasrabhojane, The University of Texas MD Anderson Cancer Center
Khalel Imanbayev, The University of Texas MD Anderson Cancer Center
Manoj Chelvanambi, The University of Texas MD Anderson Cancer Center
Michael G. White, The University of Texas MD Anderson Cancer Center
Nadim J. Ajami, The University of Texas MD Anderson Cancer Center
Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

ELISA, RBD, SARS-CoV-2, antibody

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

Partnership for Careers in Cancer Science and Medicine

Recommended Citation

Sanchez, Emilly G.; Paindelli, Claudia; Dondossola, Eleonora; Johnson, Sarah B.; Sahasrabhojane, Pranoti V.; Imanbayev, Khalel; Chelvanambi, Manoj; White, Michael G.; Ajami, Nadim J.; and Wargo, Jennifer A., "Implementation and Testing of Enzyme Linked Immunosorbent Assay for the Detection of SARS-CoV-2 Receptor Binding Domain Antibodies" (2021). Summer Experience 2021. 124.
https://openworks.mdanderson.org/sumexp21/124